Singapore markets closed

NovoCure Limited (NVCR)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
82.06-9.31 (-10.19%)
At close: 04:00PM EST
83.00 +0.94 (+1.15%)
After hours: 07:50PM EST
Full screen
Trade prices are not sourced from all markets
Previous close91.37
Open91.00
Bid82.14 x 900
Ask82.15 x 800
Day's range81.38 - 91.00
52-week range81.38 - 232.76
Volume991,366
Avg. volume557,874
Market cap8.519B
Beta (5Y monthly)0.97
PE ratio (TTM)N/A
EPS (TTM)-0.27
Earnings date23 Feb 2022 - 28 Feb 2022
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target est119.33
  • Motley Fool

    Is It Time to Buy the 3 Worst-Performing Growth Stocks of 2021?

    This year's big pullbacks are more the result of a raucous 2020, and less an indictment of these companies' prospects.

  • Motley Fool

    Is Now the Right Time to Buy NovoCure?

    NovoCure (NASDAQ: NVCR) was one of the better-performing stocks of early 2021, but the big gains came to an end in June. Is the recent plunge an opportunity to buy a great medical device stock on sale, or is it the beginning of a longer slide? NovoCure's flagship product, Optune, is a weird-looking, battery-powered hat that generates electric fields in order to disrupt cancer cell division.

  • Business Wire

    Novocure to Participate in Two Upcoming Investor Conferences

    ST. HELIER, Jersey, November 23, 2021--Novocure (NASDAQ: NVCR) announced today it will participate in two upcoming investor conferences.